PlainRecalls
FDA Devices Moderate Class II Terminated

BD Phoenix PMIC-108: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera Staphylococcus, Enterococcus, and other gram-positive cocci and gram-positive bacilli Catalog Number: 448418

Reported: January 6, 2021 Initiated: December 8, 2020 #Z-0763-2021

Product Description

BD Phoenix PMIC-108: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera Staphylococcus, Enterococcus, and other gram-positive cocci and gram-positive bacilli Catalog Number: 448418

Reason for Recall

BD Phoenix Sulfamethoxazole-trimethoprim (SXT) Resistance, false resistant SXT result with S. aureus could lead to a potential loss of access to a preferred antibiotic regimen and potential reduction in effectiveness of treatment of the infection

Details

Recalling Firm
Becton Dickinson & Co.
Units Affected
60425 eaches
Distribution
Nationwide
Location
Sparks, MD

Frequently Asked Questions

What product was recalled?
BD Phoenix PMIC-108: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera Staphylococcus, Enterococcus, and other gram-positive cocci and gram-positive bacilli Catalog Number: 448418. Recalled by Becton Dickinson & Co.. Units affected: 60425 eaches.
Why was this product recalled?
BD Phoenix Sulfamethoxazole-trimethoprim (SXT) Resistance, false resistant SXT result with S. aureus could lead to a potential loss of access to a preferred antibiotic regimen and potential reduction in effectiveness of treatment of the infection
Which agency issued this recall?
This recall was issued by the FDA Devices on January 6, 2021. Severity: Moderate. Recall number: Z-0763-2021.